{"mainPropery":{"diseaseId":8397,"diseaseName":"Methionine adenosyltransferase deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8397/methionine-adenosyltransferase-deficiency","synonyms":["MAT deficiency"],"synonyms-with-source":[{"name":"MAT deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"250850"},{"identifierType":"ORPHANET","identifierId":"168598"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/250850' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Methionine+adenosyltransferase+deficiency%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Methionine adenosyltransferase deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=hypermethioninemia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Methionine adenosyltransferase deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=168598' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/Methionine.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/PDFLibrary/Methionine-Algorithm.pdf' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_SCOT_MATDeficiency-enPro3298.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:250850' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":11378,"questionText":"What is methionine adenosyltransferase deficiency?","answerText":"<strong>Methionine adenosyltransferase deficiency</strong> is a very rare metabolic disorder resulting in an isolated increase of the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002222.htm\" target=\"_blank\">amino acid</a>  methionine in the blood (hypermethioninemia). In most cases there are no symptoms and it is usually a benign condition, but some patients may present with neurologic or developmental problems and/or bad breath. It is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <a href=\"https://ghr.nlm.nih.gov/gene/MAT1A\"><em>MAT1A</em></a> <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>. Inheritance is <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>.[1] When needed, treatment is with a diet restricting methionine.[12690][12692]<span> <a href=\"http://umm.edu/health/medical/altmed/supplement/sadenosylmethionine\" target=\"_blank\">S-adenosylmethionine (SAMe) supplementation</a> may also be useful.[12692]</span><br />","dateModified":"2016-12-03T18:54:00"},"basicQuestions":[{"questionId":11380,"questionText":"What are the signs and symptoms of methionine adenosyltransferase deficiency?","answerText":"The disease is considered benign in many cases and most patients only have isolated hypermethioninemia. However, about 50% of patients with mutations in the&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/MAT1A\"><em>MAT1A</em></a> gene have developed neurological symptoms later in life, so it cannot be considered to be a benign genetic disorder for all patients. Symptoms that have been described include:[12690][12691]<br />\r\n<ul>\r\n    <li>Problems with psychomotor development or intelligence</li>\r\n    <li>Tremor </li>\r\n    <li>Abnormal muscle contractions, </li>\r\n    <li>Lack of control involving range of movement, </li>\r\n    <li>Severe headaches, </li>\r\n    <li>Abnormal eye movements (nystagmus), </li>\r\n    <li>Impaired ability to make rapid, alternating movements (dysdiadochokinesis),</li>\r\n    <li>Increased tendon reflexes,</li>\r\n    <li>Language difficulties and learning disabilities. </li>\r\n</ul>\r\nNeurological abnormalities are more common when methionine levels in the blood are above 800&nbsp;&mu;mol/L and rare in people with lower levels. Brain images may show some changes, such as inflammation and demyelination, especially in patients with neurological problems.[12691]<br />\r\n<br />\r\nHypermethioninemia can also be associated with an unusual breath odor likely due to formation of a substance known as dimethylsulfide that results from the problem with the enzyme deficiency.[12691]<br />\r\n<br />\r\nLiver function tests in patients have been normal so far.[12691]<br />\r\n<br />\r\nMethionine adenosyltransferase deficiency is the most common cause of persistent isolated hypermethioninemia and should be suspected in people with unexplained hypermethioninemia. Also, when a patient has unexplained neurological signs and symptoms, disorders of methylation should be investigated at least by analysis of plasma amino acids.[12691]","dateModified":"2016-12-03T20:14:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12690,"authors":"","articleTitle":"Hypermethioninemia","bookWebsiteJournalTitle":"Genetics Home Reference:","date":"April, 2007","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/hypermethioninemia","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12691,"authors":"Baric I","articleTitle":"Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"September 26, 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/27671891","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11379,"questionText":"How might methionine adenosyltransferase deficiency be treated?","answerText":"All patients, even when they do not have any symptoms, should have regular neurological and cognitive testing due to the possibility of neurological symptoms. If indicated, a <a href=\"https://medlineplus.gov/ency/article/003791.htm\" target=\"_blank\">brain MRI</a> could also be done. Symptomatic patients should be treated with a methionine restricted diet if the methionine level is above 600&nbsp;&mu;mol/L. Treatment aims to get the methionine levels around 500 to 600&nbsp;&mu;mol/L.[12691][12692]  Neurological symptoms are more likely to develop when methionine levels in the blood are around 800&nbsp;&mu;mol/L.<br />\r\n<br />\r\n<a href=\"http://umm.edu/health/medical/altmed/supplement/sadenosylmethionine\" target=\"_blank\">S-adenosylmethionine (SAMe) supplementation</a>&nbsp;(AdoMet supplementation) may be indicated if clinical signs and symptoms develop while on methionine restriction. The most effective oral dose of AdoMet is unknown. Doses between 400 to 1600&nbsp;mg/day have been used in various conditions and seem to be well tolerated. Some evidence suggests that AdoMet supplementation may lead to normalization of brain changes seen on imaging.[12691]<br />","dateModified":"2016-12-03T19:48:00","resourceClassificationName":"Treatment","references":[{"referenceId":12691,"authors":"Baric I","articleTitle":"Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders","bookWebsiteJournalTitle":"J Inherit Metab Dis","date":"September 26, 2016","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/27671891","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12692,"authors":"Labrune P & cols","articleTitle":"Familial hypermethioninemia partially responsive to dietary restriction","bookWebsiteJournalTitle":"J. Pediat","date":"1990","volume":"117","pages":"220-226","url":"https://www.ncbi.nlm.nih.gov/pubmed/2380820","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12115,"relatedDiseaseName":"Hypermethioninemia","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13657,"phenoTypeName":"CNS demyelination","percentRanges":"-"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","percentRanges":"-"},{"phenoTypeId":1882,"phenoTypeName":"Halitosis","percentRanges":"-"},{"phenoTypeId":10927,"phenoTypeName":"Hypermethioninemia","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":11164,"phenoTypeName":"Peripheral demyelination","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Methionine_adenosyltransferase_deficiency"}